Serum Elabela/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes
JournalCellular Physiology and Biochemistry
PublisherS. Karger AG
MetadataShow full item record
AbstractBackground/Aims: Elabela (ELA) or Toddler is a recently identified hormone that plays a crucial role in embryonic development through the activation of the apelin receptor (APJ). Our previous study indicated that ELA is highly expressed in adult kidney and the ELA receptor signaling pathway is functional in mammalian systems. Whereas nothing is yet known regarding ELA and diabetic kidney disease (DKD). Here, we evaluated the relationship between serum ELA levels and albuminuria in patients with type 2 diabetes (T2D). Methods: An observational study involving 80 patients divided into groups according to their baseline urinary albumin/creatinine ratio (ACR): Group 1 (ACR ≤ 29 mg/g), Group 2 (ACR = 30–299 mg/g), Group 3 (ACR ≥ 300 mg/g with normal serum creatinine), and Group 4 (ACR ≥ 300 mg/g with increased serum creatinine). The demographic, clinical, and biochemical variables including serum ELA were obtained or measured through disease history, physical examination, or laboratory evidence. Results: The results showed that the serum ELA levels decreased gradually with the deterioration of DKD from the stages of normal albuminuria, microalbuminuria, macroalbuminuria, to macroalbuminuria and elevated serum creatinine. In addition, ELA had a significantly negative correlation with ACR (r = -0.561, P < 0.001), retinopathy (r = -0.424, P < 0.001), serum creatinine (r = -0.269, P = 0.016), SBP (r = -0.249, P = 0.026), DBP (r = -0.261, P = 0.020) and a positive correlation with eGFR (r = 0.318, P = 0.004). Furthermore, stepwise multiple linear regression analysis showed that ACR, retinopathy, and LDL-C were considered the most relevant variables to ELA, and ELA, retinopathy, eGFR, and age were important predictors for ACR (t = -4.546, P = 0.000). Conclusions: To our knowledge, this is the first study to explore the clinical relationship between ELA levels and CKD. Decreased serum ELA levels might be a significant clinical predictor in patients with DKD or even as a promising agent for treating CKD patients. Copyright 2018 The Author(s). Published by S. Karger AG, Basel.
SponsorsThis study was supported by the National Natural Science Foundation of China Grant Award, Jiangsu Provincial Commission of Health and Family Planning, China and Jiangsu Provincial Key Laboratory of Automotive Engineering, China.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85052456593&doi=10.1159%2f000492093&partnerID=40&md5=643ac7cbd68cea302c97053f72dc60e8; http://hdl.handle.net/10713/9412
- Elabela levels in patients with type 2 diabetes: can it be a marker for diabetic nephropathy?
- Authors: Onalan E, Doğan Y, Onalan E, Gozel N, Buran I, Donder E
- Issue date: 2020 Jun
- Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
- Authors: Chen CC, Susanto H, Chuang WH, Liu TY, Wang CH
- Issue date: 2016 Jan 7
- Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
- Authors: Shao Y, Lv C, Yuan Q, Wang Q
- Issue date: 2016
- Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
- Authors: Jeon YK, Kim MR, Huh JE, Mok JY, Song SH, Kim SS, Kim BH, Lee SH, Kim YK, Kim IJ
- Issue date: 2011 Feb
- Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
- Authors: Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H
- Issue date: 2008 Nov-Dec